Cargando…

Benign serous ovarian tumour: a redefining moment?

Detalles Bibliográficos
Autores principales:	Hunter, Sally, Gorringe, Kylie, Anglesio, Michael, Sharma, Raghwa, Gilks, Blake, deFazio, Anna, Huntsman, David, Campbell, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327265/ http://dx.doi.org/10.1186/1897-4287-10-S2-A83

Ejemplares similares

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
por: Hunter, Sally M., et al.
Publicado: (2015)

Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
por: Hunter, Sally M., et al.
Publicado: (2020)

Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma
por: Gilks, C. Blake
Publicado: (2010)

A rational approach to cancer therapy
por: Gorringe, Kylie L, et al.
Publicado: (2008)

Integrated genomic analysis and functional characterisation of novel oncogenes in ovarian cancer
por: Davis, SJ, et al.
Publicado: (2012)

The Oncogenic Roles of DICER1 RNase IIIb Domain Mutations in Ovarian Sertoli-Leydig Cell Tumors()()
por: Wang, Yemin, et al.
Publicado: (2015)

Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
por: Cheasley, Dane, et al.
Publicado: (2022)

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2010)

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
por: Tone, Alicia A, et al.
Publicado: (2014)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
por: Bashashati, Ali, et al.
Publicado: (2013)

Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
por: Hanker, L. C., et al.
Publicado: (2021)

The Australian Ovarian Cancer Study
por: Traficante, N, et al.
Publicado: (2012)

Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
por: Helland, Åslaug, et al.
Publicado: (2011)

Markers of T Cell Infiltration and Function Associate with Favorable Outcome in Vascularized High-Grade Serous Ovarian Carcinoma
por: Townsend, Katelin N., et al.
Publicado: (2013)

Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study
por: Hung, J, et al.
Publicado: (2012)

From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
por: Subramanian, Deepak N., et al.
Publicado: (2020)

Soluble osteopontin concentrations in serum and ascites of women with advanced serous ovarian cancer
por: Černe, Katarina, et al.
Publicado: (2012)

When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
por: Salazar, Carolina, et al.
Publicado: (2018)

Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary.
por: Orre, M., et al.
Publicado: (1998)

The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012)

Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours
por: Birch, Ashley H., et al.
Publicado: (2011)

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
por: Harrington, Brittney S, et al.
Publicado: (2016)

High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
por: Baumbusch, Lars O., et al.
Publicado: (2013)

Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials
por: Nugawela, Devindee, et al.
Publicado: (2023)

Rapid fluorometric detection of drug resistant tumour cells.
por: deFazio, A., et al.
Publicado: (1985)

MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary
por: Lee, Cheng-Han, et al.
Publicado: (2009)

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
por: Santin, A D, et al.
Publicado: (2004)

Ovarian hemangioma occurring synchronously with serous papillary carcinoma of the ovary and benign endometrial polyp
por: Akbulut, Metin, et al.
Publicado: (2008)

Identification of clinical and molecular features of recurrent serous borderline ovarian tumour
por: Lu, Ziyang, et al.
Publicado: (2022)

A serous borderline ovarian tumour in a transgender male adolescent
por: Millington, Kate, et al.
Publicado: (2020)

A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention
por: Hanley, Gillian E., et al.
Publicado: (2018)

Analysis of the Mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer
por: Davis, Sally J, et al.
Publicado: (2011)

Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
por: Christie, Elizabeth L., et al.
Publicado: (2019)

Glutathione S-transferase expression in benign and malignant ovarian tumours.
por: Green, J. A., et al.
Publicado: (1993)

Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything
por: Kader, Tanjina, et al.
Publicado: (2022)

Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors
por: Ouellet, Véronique, et al.
Publicado: (2008)

The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
por: Youssef, Arkan, et al.
Publicado: (2021)

Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
por: Gorringe, Kylie L., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qobn2lcfo0m0ucidhf4li5tf7r